Outlook Therapeutics, Inc.·4

Sep 22, 5:14 PM ET

Haddadin Yezan Munther 4

4 · Outlook Therapeutics, Inc. · Filed Sep 22, 2020

Insider Transaction Report

Form 4
Period: 2020-09-22
Transactions
  • Purchase

    Common Stock

    2020-09-22$0.72/sh+10,000$7,24510,000 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION